Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells

被引:57
作者
Dhillon, Jasvir
Andries, Koen [2 ]
Phillips, Patrick P. J. [3 ]
Mitchison, Denis A. [1 ]
机构
[1] St Georges Univ London, Div Cellular & Mol Med, London SW17 0RE, England
[2] Johnson & Johnson, Dept Antimicrobial Res, Tibotec BVBA, Beerse, Belgium
[3] MRC, Clin Trials Unit, London, England
关键词
Diarylquinoline TMC207; Intra-cellular activity; Peritoneal macrophages; J774 cell line; MOUSE PERITONEAL-MACROPHAGES; PENETRATION; MICROTI;
D O I
10.1016/j.tube.2010.07.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The bactericidal activities of the diarylquinoline TMC207 in a liquid culture medium started with a bacteriostatic phase lasting about 7 days and then continued with a dose-related bactericidal phase. In comparison, its intra-cellular activity in primary mouse peritoneal macrophages (PM) and in the J774 macrophage-like cell line had little or no static phase so that the bactericidal kill was evident by 5-7 days presumably due to low bacterial ATP levels. Bactericidal activities in the three systems were compared by estimating [1] the rate of bacterial killing (K) during exposure to 0.12-1.0 mu g/ml TMC207 which were similar at, -0.35 in the J774 cells and -0.27 in mouse PM (p = 0.6) with each lower than -0.11 in extracellular cultures (p < 0.001) and [2] the TMC207 concentration at the intersection between the curve relating cfu count to TMC207 concentration and the cfu count at day-0, defined as the static concentration. Static concentrations were 0.22 mu g/ml for extra-cellular cultures, 0.17 mu g/ml for mouse PM and 0.06 mu g/ml for J774 cells, significantly lower than the extra-cellular value (p < 0.001). Thus, the intracellular activity of TMC207 is clearly greater than its extra-cellular activity mainly because the preliminary static phase was a shorter or absent. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:301 / 305
页数:5
相关论文
共 10 条
[1]   A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis [J].
Andries, K ;
Verhasselt, P ;
Guillemont, J ;
Göhlmann, HWH ;
Neefs, JM ;
Winkler, H ;
Van Gestel, J ;
Timmerman, P ;
Zhu, M ;
Lee, E ;
Williams, P ;
de Chaffoy, D ;
Huitric, E ;
Hoffner, S ;
Cambau, E ;
Truffot-Pernot, C ;
Lounis, N ;
Jarlier, V .
SCIENCE, 2005, 307 (5707) :223-227
[2]  
CANETTI G, 1955, TUBERCLE BACILLUS PU, P62
[3]   ACTIVITY AND PENETRATION OF ANTITUBERCULOSIS DRUGS IN MOUSE PERITONEAL-MACROPHAGES INFECTED WITH MYCOBACTERIUM-MICROTI OV254 [J].
DHILLON, J ;
MITCHISON, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1255-1259
[4]   ACTIVITY INVITRO OF RIFABUTIN, FCE-22807, RIFAPENTINE, AND RIFAMPIN AGAINST MYCOBACTERIUM-MICROTI AND MYCOBACTERIUM-TUBERCULOSIS AND THEIR PENETRATION INTO MOUSE PERITONEAL-MACROPHAGES [J].
DHILLON, J ;
MITCHISON, DA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (01) :212-214
[5]   The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis [J].
Diacon, Andreas H. ;
Pym, Alexander ;
Grobusch, Martin ;
Patientia, Ramonde ;
Rustomjee, Roxana ;
Page-Shipp, Liesl ;
Pistorius, Christoffel ;
Krause, Rene ;
Bogoshi, Mampedi ;
Churchyard, Gavin ;
Venter, Amour ;
Allen, Jenny ;
Palomino, Juan Carlos ;
De Marez, Tine ;
van Heeswijk, Rolf P. G. ;
Lounis, Nacer ;
Meyvisch, Paul ;
Verbeeck, Johan ;
Parys, Wim ;
de Beule, Karel ;
Andries, Koen ;
Mc Neeley, David F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (23) :2397-2405
[6]   Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum [J].
Garton, Natalie J. ;
Waddell, Simon J. ;
Sherratt, Anna L. ;
Lee, Su-Min ;
Smith, Rebecca J. ;
Senner, Claire ;
Hinds, Jason ;
Rajakumar, Kumar ;
Adegbola, Richard A. ;
Besra, Gurdyal S. ;
Butcher, Philip D. ;
Barer, Michael R. .
PLOS MEDICINE, 2008, 5 (04) :634-645
[7]   Mycobacterium tuberculosis in the extracellular compartment:: an underestimated adversary [J].
Grosset, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) :833-836
[8]   Mycobacterium tuberculosis resides in nonacidified vacuoles in endocytically competent alveolar macrophages from patients with tuberculosis and HIV infection [J].
Mwandumba, HC ;
Russell, DG ;
Nyirenda, MH ;
Anderson, J ;
White, SA ;
Molyneux, ME ;
Squire, SB .
JOURNAL OF IMMUNOLOGY, 2004, 172 (07) :4592-4598
[9]   Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis [J].
Rustomjee, R. ;
Diacon, A. H. ;
Allen, J. ;
Venter, A. ;
Reddy, C. ;
Patientia, R. F. ;
Mthiyane, T. C. P. ;
De Marez, T. ;
van Heeswijk, R. ;
Kerstens, R. ;
Kou, A. ;
De Beule, K. ;
Donald, P. R. ;
McNeeley, D. F. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (08) :2831-2835
[10]   Transcriptional adaptation of Mycobacterium tuberculosis within macrophages:: Insights into the phagosomal environment [J].
Schnappinger, D ;
Ehrt, S ;
Voskuil, MI ;
Liu, Y ;
Mangan, JA ;
Monahan, IM ;
Dolganov, G ;
Efron, B ;
Butcher, PD ;
Nathan, C ;
Schoolnik, GK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (05) :693-704